Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	succinate-CoA ligase (GDP-forming) activity	SUCLG2 SUCLG1	2.15e-05	2	93	2	GO:0004776
GeneOntologyMolecularFunction	succinate-CoA ligase (ADP-forming) activity	SUCLG2 SUCLG1	6.42e-05	3	93	2	GO:0004775
GeneOntologyMolecularFunction	succinate-CoA ligase activity	SUCLG2 SUCLG1	6.42e-05	3	93	2	GO:0004774
GeneOntologyMolecularFunction	SH3 domain binding	ZNF106 CTTNBP2 MAPT TP53BP2 SYNGAP1	5.50e-04	143	93	5	GO:0017124
GeneOntologyMolecularFunction	glucuronosyltransferase activity	UGT2A2 UGT2B15 UGT2B17	5.75e-04	35	93	3	GO:0015020
GeneOntologyCellularComponent	succinate-CoA ligase complex (GDP-forming)	SUCLG2 SUCLG1	1.87e-05	2	91	2	GO:0045244
GeneOntologyCellularComponent	succinate-CoA ligase complex	SUCLG2 SUCLG1	5.61e-05	3	91	2	GO:0042709
GeneOntologyCellularComponent	postsynapse	FLNA DLGAP1 CTTNBP2 DST GOPC MAP4 MAPT SLC4A10 PLCB1 RPS23 MAP2K1 EPHA4 SYNGAP1	4.52e-04	1018	91	13	GO:0098794
GeneOntologyCellularComponent	postsynaptic density	DLGAP1 DST GOPC MAP4 MAPT MAP2K1 EPHA4 SYNGAP1	7.85e-04	451	91	8	GO:0014069
GeneOntologyCellularComponent	axonal growth cone	FLNA MAPT EPHA4	9.92e-04	45	91	3	GO:0044295
GeneOntologyCellularComponent	cell-cell junction	FLNA FAT2 DST DSC1 AHNAK AMOTL1 PARD3B PCDH9 EPHA4	1.09e-03	591	91	9	GO:0005911
GeneOntologyCellularComponent	asymmetric synapse	DLGAP1 DST GOPC MAP4 MAPT MAP2K1 EPHA4 SYNGAP1	1.13e-03	477	91	8	GO:0032279
GeneOntologyCellularComponent	neuron projection cytoplasm	DST MAPT MAP2K1 RAB27B	1.36e-03	110	91	4	GO:0120111
GeneOntologyCellularComponent	postsynaptic specialization	DLGAP1 DST GOPC MAP4 MAPT MAP2K1 EPHA4 SYNGAP1	1.58e-03	503	91	8	GO:0099572
GeneOntologyCellularComponent	axon	FLNA TSHZ3 DST MAP4 MAPT SBF2 SLC4A10 MAP2K1 PCDH9 RAB27B EPHA4	1.67e-03	891	91	11	GO:0030424
Domain	TAU_MAP_1	MAP4 MAPT	7.02e-05	3	91	2	PS00229
Domain	TAU_MAP_2	MAP4 MAPT	7.02e-05	3	91	2	PS51491
Domain	Tubulin-binding	MAP4 MAPT	7.02e-05	3	91	2	PF00418
Domain	MAP_tubulin-bd_rpt	MAP4 MAPT	7.02e-05	3	91	2	IPR001084
Domain	MAP2/MAP4/Tau	MAP4 MAPT	7.02e-05	3	91	2	IPR027324
Domain	CoA_ligase	SUCLG2 SUCLG1	1.40e-04	4	91	2	IPR005811
Domain	Ligase_CoA	SUCLG2 SUCLG1	1.40e-04	4	91	2	PF00549
Domain	Succinyl-CoA_synth-like	SUCLG2 SUCLG1	1.40e-04	4	91	2	IPR016102
Domain	-	SUCLG2 SUCLG1	1.40e-04	4	91	2	3.40.50.261
Domain	Actinin_actin-bd_CS	FLNA DST PLS3	1.85e-04	23	91	3	IPR001589
Domain	ACTININ_2	FLNA DST PLS3	1.85e-04	23	91	3	PS00020
Domain	ACTININ_1	FLNA DST PLS3	1.85e-04	23	91	3	PS00019
Domain	LisH	TBL1Y TBL1XR1	8.27e-04	9	91	2	PF08513
Domain	CH	FLNA DST PLS3	3.93e-03	65	91	3	SM00033
Domain	RCC1	HERC3 HERC6	4.21e-03	20	91	2	PF00415
Domain	RCC1_1	HERC3 HERC6	4.64e-03	21	91	2	PS00625
Domain	RCC1_2	HERC3 HERC6	4.64e-03	21	91	2	PS00626
Domain	UDPGT	UGT2B15 UGT2B17	4.64e-03	21	91	2	PF00201
Domain	RCC1_3	HERC3 HERC6	4.64e-03	21	91	2	PS50012
Domain	UDPGT	UGT2B15 UGT2B17	4.64e-03	21	91	2	PS00375
Domain	UDP_glucos_trans	UGT2B15 UGT2B17	4.64e-03	21	91	2	IPR002213
Domain	CH	FLNA DST PLS3	4.84e-03	70	91	3	PF00307
Domain	-	FLNA DST PLS3	5.04e-03	71	91	3	1.10.418.10
Domain	Reg_chr_condens	HERC3 HERC6	5.09e-03	22	91	2	IPR000408
Domain	-	HERC3 HERC6	5.09e-03	22	91	2	2.130.10.30
Domain	CH	FLNA DST PLS3	5.44e-03	73	91	3	PS50021
Domain	RCC1/BLIP-II	HERC3 HERC6	5.56e-03	23	91	2	IPR009091
Domain	CH-domain	FLNA DST PLS3	5.87e-03	75	91	3	IPR001715
Domain	zf-C2H2	SP1 ZNF106 TSHZ3 ZNF776 ZFP90 ZNF827 ZNF451 MECOM ZNF626	6.61e-03	693	91	9	PF00096
Domain	HECT	HERC3 HERC6	7.61e-03	27	91	2	PF00632
Domain	HECTc	HERC3 HERC6	7.61e-03	27	91	2	SM00119
Domain	HECT_dom	HERC3 HERC6	7.61e-03	27	91	2	IPR000569
Domain	HECT	HERC3 HERC6	7.61e-03	27	91	2	PS50237
Domain	LisH	TBL1Y TBL1XR1	8.17e-03	28	91	2	SM00667
Domain	LisH	TBL1Y TBL1XR1	8.17e-03	28	91	2	IPR006594
Domain	LISH	TBL1Y TBL1XR1	8.17e-03	28	91	2	PS50896
Pathway	REACTOME_NOTCH_HLH_TRANSCRIPTION_PATHWAY	TBL1Y TBL1XR1 MAML3	1.55e-04	23	65	3	MM14954
Pathway	REACTOME_GLUCURONIDATION	UGT2A2 UGT2B15 UGT2B17	1.77e-04	24	65	3	MM14599
Pathway	REACTOME_GLUCURONIDATION	UGT2A2 UGT2B15 UGT2B17	2.00e-04	25	65	3	M17787
Pathway	WP_GLUCURONIDATION	UGT2A2 UGT2B15 UGT2B17	2.00e-04	25	65	3	MM15820
Pathway	WP_GLUCURONIDATION	UGT2A2 UGT2B15 UGT2B17	2.26e-04	26	65	3	M39404
Pathway	WP_FRAGILE_X_SYNDROME	PDK1 PLCB1 MAP2K1 EPHA4 SYNGAP1	2.35e-04	121	65	5	M39804
Pubmed	A human MAP kinase interactome.	HIPK3 SP1 FLNA ZNF106 DLGAP1 DST ZNF451 PLCB1 CPLANE1 MAP2K1	7.43e-07	486	93	10	20936779
Pubmed	Expression of UDP Glucuronosyltransferases 2B15 and 2B17 is associated with methylation status in prostate cancer cells.	UGT2B15 UGT2B17	7.07e-06	2	93	2	32660355
Pubmed	Delta-secretase (AEP) mediates tau-splicing imbalance and accelerates cognitive decline in tauopathies.	LGMN MAPT	7.07e-06	2	93	2	30373880
Pubmed	Cleavage of tau by asparagine endopeptidase mediates the neurofibrillary pathology in Alzheimer's disease.	LGMN MAPT	7.07e-06	2	93	2	25326800
Pubmed	The UDP glucuronosyltransferase gene superfamily: suggested nomenclature based on evolutionary divergence.	UGT2B15 UGT2B17	7.07e-06	2	93	2	1909870
Pubmed	Androgen glucuronidation: an unexpected target for androgen deprivation therapy, with prognosis and diagnostic implications.	UGT2B15 UGT2B17	7.07e-06	2	93	2	24121496
Pubmed	Novel associations of UDP-glucuronosyltransferase 2B gene variants with prostate cancer risk in a multiethnic study.	UGT2B15 UGT2B17	7.07e-06	2	93	2	24267955
Pubmed	Differential expression of the androgen-conjugating UGT2B15 and UGT2B17 enzymes in prostate tumor cells during cancer progression.	UGT2B15 UGT2B17	7.07e-06	2	93	2	22170718
Pubmed	Localization of UDP glucuronosyltransferase gene(s) on mouse chromosome 5.	UGT2B15 UGT2B17	7.07e-06	2	93	2	3105095
Pubmed	UDP-glucuronosyltransferase 2B15 (UGT2B15) and UGT2B17 enzymes are major determinants of the androgen response in prostate cancer LNCaP cells.	UGT2B15 UGT2B17	7.07e-06	2	93	2	17848572
Pubmed	Androgen and Estrogen Receptors in Breast Cancer Coregulate Human UDP-Glucuronosyltransferases 2B15 and 2B17.	UGT2B15 UGT2B17	7.07e-06	2	93	2	27496708
Pubmed	The uridine diphosphate glucuronosyltransferase 2B15 D85Y and 2B17 deletion polymorphisms predict the glucuronidation pattern of androgens and fat mass in men.	UGT2B15 UGT2B17	7.07e-06	2	93	2	17698910
Pubmed	Angiopoietin1 contributes to the maintenance of cell quiescence in EVI1(high) leukemia cells.	ANGPT1 MECOM	7.07e-06	2	93	2	22033412
Pubmed	Dissecting indirect genetic effects from peers in laboratory mice.	DLGAP1 EPHA4	7.07e-06	2	93	2	34311762
Pubmed	Mouse UDP glucuronosyltransferase. cDNA and complete amino acid sequence and regulation.	UGT2B15 UGT2B17	7.07e-06	2	93	2	3117546
Pubmed	Direct and Indirect Effects of Filamin A on Tau Pathology in Neuronal Cells.	FLNA MAPT	7.07e-06	2	93	2	36399251
Pubmed	Comprehensive Characterization of Mouse UDP-Glucuronosyltransferase (Ugt) Belonging to the Ugt2b Subfamily: Identification of Ugt2b36 as the Predominant Isoform Involved in Morphine Glucuronidation.	UGT2B15 UGT2B17	7.07e-06	2	93	2	28228532
Pubmed	Cellular specific expression of the androgen-conjugating enzymes UGT2B15 and UGT2B17 in the human prostate epithelium.	UGT2B15 UGT2B17	7.07e-06	2	93	2	15666817
Pubmed	Copy-number variations (CNVs) of the human sex steroid metabolizing genes UGT2B17 and UGT2B28 and their associations with a UGT2B15 functional polymorphism.	UGT2B15 UGT2B17	2.12e-05	3	93	2	19572376
Pubmed	Genetic evidence for the expression of ATP- and GTP-specific succinyl-CoA synthetases in multicellular eucaryotes.	SUCLG2 SUCLG1	2.12e-05	3	93	2	9765291
Pubmed	Epigenetic regulation of steroid inactivating UDP-glucuronosyltransferases by microRNAs in prostate cancer.	UGT2B15 UGT2B17	2.12e-05	3	93	2	26385605
Pubmed	The Rps23rg gene family originated through retroposition of the ribosomal protein s23 mRNA and encodes proteins that decrease Alzheimer's beta-amyloid level and tau phosphorylation.	MAPT RPS23	2.12e-05	3	93	2	20650958
Pubmed	Activation of asparaginyl endopeptidase leads to Tau hyperphosphorylation in Alzheimer disease.	LGMN MAPT	2.12e-05	3	93	2	23640887
Pubmed	Regulation of Human UGT2B15 and UGT2B17 by miR-376c in Prostate Cancer Cell Lines.	UGT2B15 UGT2B17	2.12e-05	3	93	2	26163549
Pubmed	Forkhead box protein A1 regulates UDP-glucuronosyltransferase 2B15 gene transcription in LNCaP prostate cancer cells.	UGT2B15 UGT2B17	2.12e-05	3	93	2	20736324
Pubmed	Effects of three microtubule-associated proteins (MAP2, MAP4, and Tau) on microtubules' physical properties and neurite morphology.	MAP4 MAPT	2.12e-05	3	93	2	37258650
Pubmed	Genetic variations in UGT2B28, UGT2B17, UGT2B15 genes and the risk of prostate cancer: A case-control study.	UGT2B15 UGT2B17	2.12e-05	3	93	2	28882566
Pubmed	Expression of two succinyl-CoA synthetases with different nucleotide specificities in mammalian tissues.	SUCLG2 SUCLG1	2.12e-05	3	93	2	15234968
Pubmed	Tartryl-CoA inhibits succinyl-CoA synthetase.	SUCLG2 SUCLG1	2.12e-05	3	93	2	32627745
Pubmed	Noncentrosomal microtubules and type II myosins potentiate epidermal cell adhesion and barrier formation.	MAP4 MAPT	2.12e-05	3	93	2	23091070
Pubmed	Interaction of p38 and Sp1 in a mechanical force-induced, beta 1 integrin-mediated transcriptional circuit that regulates the actin-binding protein filamin-A.	SP1 FLNA	2.12e-05	3	93	2	12324467
Pubmed	Activators of the farnesoid X receptor negatively regulate androgen glucuronidation in human prostate cancer LNCAP cells.	UGT2B15 UGT2B17	2.12e-05	3	93	2	17988216
Pubmed	Tissue distribution and relative gene expression of UDP-glucuronosyltransferases (2B7, 2B15, 2B17) in the human fetus.	UGT2B15 UGT2B17	2.12e-05	3	93	2	23223495
Pubmed	Tau promoter confers neuronal specificity and binds Sp1 and AP-2.	SP1 MAPT	2.12e-05	3	93	2	10987820
Pubmed	The Angiopoietin-1 Variant COMP-Ang1 Enhances BMP2-Induced Bone Regeneration with Recruiting Pericytes in Critical Sized Calvarial Defects.	ANGPT1 COMP	2.12e-05	3	93	2	26465321
Pubmed	Androgen receptor mediates the expression of UDP-glucuronosyltransferase 2 B15 and B17 genes.	UGT2B15 UGT2B17	2.12e-05	3	93	2	18302198
Pubmed	The nuclear receptor Shp regulates morphine withdrawal syndrome via modulation of Ugt2b expression in mice.	UGT2B15 UGT2B17	2.12e-05	3	93	2	30689982
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	FLNA DLGAP1 CTTNBP2 DST MAP4 MAPT PDK1 SLC4A10 RPS23 SUCLG1 MAP2K1 PLS3 TP53BP2 SYNGAP1	2.65e-05	1431	93	14	37142655
Pubmed	The RNA binding protein MEX3A promotes tumor progression of breast cancer by post-transcriptional regulation of IGFBP4.	FLNA DST AHNAK AMOTL1 E2F3 PRPF8 TP53BP2	3.18e-05	332	93	7	37433992
Pubmed	USP7 targets XIAP for cancer progression: Establishment of a p53-independent therapeutic avenue for glioma.	FLNA FAT2 DST AHNAK PCARE PRPF8	4.07e-05	234	93	6	36243803
Pubmed	USP45 and Spindly are part of the same complex implicated in cell migration.	FLNA CTTNBP2 AHNAK RPS23 PRPF8 AGBL1	4.17e-05	235	93	6	30258100
Pubmed	Qualitative and quantitative analyses of protein phosphorylation in naive and stimulated mouse synaptosomal preparations.	DLGAP1 DST MAP4 MAPT SLC4A10 PLCB1 SYNGAP1	4.21e-05	347	93	7	17114649
Pubmed	Norepinephrine metabolite DOPEGAL activates AEP and pathological Tau aggregation in locus coeruleus.	LGMN MAPT	4.23e-05	4	93	2	31793911
Pubmed	Interaction of Sp1 with the growth- and cell cycle-regulated transcription factor E2F.	SP1 E2F3	4.23e-05	4	93	2	8657141
Pubmed	Phosphorylation of microtubule-associated proteins MAP2 and MAP4 by the protein kinase p110mark. Phosphorylation sites and regulation of microtubule dynamics.	MAP4 MAPT	4.23e-05	4	93	2	8631898
Pubmed	Calcitrol (1alpha,25-dihydroxyvitamin D3) inhibits androgen glucuronidation in prostate cancer cells.	UGT2B15 UGT2B17	4.23e-05	4	93	2	18281521
Pubmed	Impacts of the Glucuronidase Genotypes UGT1A4, UGT2B7, UGT2B15 and UGT2B17 on Tamoxifen Metabolism in Breast Cancer Patients.	UGT2B15 UGT2B17	4.23e-05	4	93	2	26176234
Pubmed	Context-Dependent Gait Choice Elicited by EphA4 Mutation in Lbx1 Spinal Interneurons.	MAPT EPHA4	4.23e-05	4	93	2	26924434
Pubmed	ApoE4 inhibition of VMAT2 in the locus coeruleus exacerbates Tau pathology in Alzheimer's disease.	LGMN MAPT	4.23e-05	4	93	2	33895869
Pubmed	An organelle-specific protein landscape identifies novel diseases and molecular mechanisms.	TLK2 GOPC TBC1D1 AHNAK AMOTL1 PCARE SUCLG1 PRPF8 PCDH9 PLS3 TCTN1 TP53BP2 FAM110B	4.98e-05	1321	93	13	27173435
Pubmed	Neuron-specific protein network mapping of autism risk genes identifies shared biological mechanisms and disease-relevant pathologies.	PCNP FLNA DLGAP1 GOPC MAP4 MAPT PDK1 SLC4A10 PLCB1 RPS23 SUCLG1 SYNGAP1	5.21e-05	1139	93	12	36417873
Pubmed	Genome-scale RNAi screen for host factors required for HIV replication.	TLK2 CD4 NBEAL2 SBF2 MECOM KRBA2 SUCLG2	5.40e-05	361	93	7	18976975
Pubmed	Human ISG15 conjugation targets both IFN-induced and constitutively expressed proteins functioning in diverse cellular pathways.	LGMN FLNA MAP4 AHNAK PLS3	5.69e-05	152	93	5	16009940
Pubmed	Delta-Secretase Phosphorylation by SRPK2 Enhances Its Enzymatic Activity, Provoking Pathogenesis in Alzheimer's Disease.	LGMN MAPT	7.04e-05	5	93	2	28826672
Pubmed	Learning and reaction times in mouse touchscreen tests are differentially impacted by mutations in genes encoding postsynaptic interacting proteins SYNGAP1, NLGN3, DLGAP1, DLGAP2 and SHANK2.	DLGAP1 SYNGAP1	7.04e-05	5	93	2	33347690
Pubmed	Hepatic deficiency in transcriptional cofactor TBL1 promotes liver steatosis and hypertriglyceridemia.	TBL1Y TBL1XR1	7.04e-05	5	93	2	21459324
Pubmed	HIV infection of T cells: actin-in and actin-out.	FLNA CD4	7.04e-05	5	93	2	19366992
Pubmed	c-Src regulates δ-secretase activation and truncated Tau production by phosphorylating the E3 ligase Traf6.	LGMN MAPT	7.04e-05	5	93	2	37977223
Pubmed	The human HERC family of ubiquitin ligases: novel members, genomic organization, expression profiling, and evolutionary aspects.	HERC3 HERC6	7.04e-05	5	93	2	15676274
Pubmed	Aerobic glycolysis tunes YAP/TAZ transcriptional activity.	MAP4 AHNAK AMOTL1 PRPF8 TP53BP2	7.70e-05	162	93	5	25796446
Pubmed	Zbtb20 is essential for the specification of CA1 field identity in the developing hippocampus.	TSHZ3 MAN1A1 EPHA4	8.68e-05	32	93	3	20308569
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	ZFP90 DST NBEAL2 BMS1 PLCB1 E2F3 RPRD2 ARHGAP20	8.92e-05	529	93	8	14621295
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	ZNF106 DST MAP4 MAPT TBC1D1 AHNAK PARD3B MAP2K1 TP53BP2 FAM110B	1.04e-04	861	93	10	36931259
Pubmed	The regulation of E2F by pRB-family proteins.	SP1 E2F3	1.05e-04	6	93	2	9694791
Pubmed	Evaluation of potential effects of Plastin 3 overexpression and low-dose SMN-antisense oligonucleotides on putative biomarkers in spinal muscular atrophy mice.	COMP PLS3	1.05e-04	6	93	2	30188931
Pubmed	Actin-binding protein-280 binds the stress-activated protein kinase (SAPK) activator SEK-1 and is required for tumor necrosis factor-alpha activation of SAPK in melanoma cells.	FLNA MAP2K1	1.05e-04	6	93	2	9006895
Pubmed	Sp1 and AP-1 regulate expression of the human gene VIL2 in esophageal carcinoma cells.	SP1 MAP2K1	1.05e-04	6	93	2	19164283
Pubmed	Structure of the MeCP2-TBLR1 complex reveals a molecular basis for Rett syndrome and related disorders.	TBL1Y TBL1XR1	1.05e-04	6	93	2	28348241
Pubmed	Steroidogenic enzymes and stem cell markers are upregulated during androgen deprivation in prostate cancer.	UGT2B15 UGT2B17	1.05e-04	6	93	2	21365123
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	PCNP FLNA MAP4 AHNAK AMOTL1 RPRD2 PLS3 TP53BP2	1.15e-04	549	93	8	38280479
Pubmed	A Multipronged Unbiased Strategy Guides the Development of an Anti-EGFR/EPHA2-Bispecific Antibody for Combination Cancer Therapy.	DST GOPC PDK1 PLCB1 PARD3B RAB27B EPHA4	1.40e-04	421	93	7	36976175
Pubmed	Linking functions: an additional role for an intrinsically disordered linker domain in the transcriptional coactivator CBP.	HIPK3 ZNF106 ZNF451	1.46e-04	38	93	3	28680062
Pubmed	Amphiphysin I cleavage by asparagine endopeptidase leads to tau hyperphosphorylation and synaptic dysfunction.	LGMN MAPT	1.47e-04	7	93	2	34018922
Pubmed	Weak activity of UDP-glucuronosyltransferase toward Bisphenol analogs in mouse perinatal development.	UGT2B15 UGT2B17	1.47e-04	7	93	2	26074487
Pubmed	The nuclear receptor corepressor deacetylase activating domain is essential for repression by thyroid hormone receptor.	TBL1Y TBL1XR1	1.47e-04	7	93	2	15695367
Pubmed	Comparative whole-genome transcriptome analysis in renal cell populations reveals high tissue specificity of MAPK/ERK targets in embryonic kidney.	MAP2K1 SIX2	1.47e-04	7	93	2	35550069
Pubmed	The Z-disc proteins myotilin and FATZ-1 interact with each other and are connected to the sarcolemma via muscle-specific filamins.	FLNA MYOZ1	1.47e-04	7	93	2	16076904
Pubmed	The methylcytosine dioxygenase Tet2 promotes DNA demethylation and activation of cytokine gene expression in T cells.	CD4 MAPT	1.47e-04	7	93	2	25862091
Pubmed	Zbtb7c is a molecular 'off' and 'on' switch of Mmp gene transcription.	TBL1Y TBL1XR1	1.47e-04	7	93	2	27646874
Pubmed	Highly homologous HERC proteins localize to endosomes and exhibit specific interactions with hPLIC and Nm23B.	HERC3 HERC6	1.47e-04	7	93	2	18535780
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	HIPK3 CDS1 MAP4 ZNF827 MAPT TBC1D1 SBF2 PARD3B E2F3 RPRD2 ARMC2 TBL1XR1 MAML3	1.65e-04	1489	93	13	28611215
Pubmed	Identification of proximal SUMO-dependent interactors using SUMO-ID.	TLK2 PCNP FLNA ZNF106 MAP4 AHNAK ZNF451	1.94e-04	444	93	7	34795231
Pubmed	Novel link between E2F and p53: proapoptotic cofactors of p53 are transcriptionally upregulated by E2F.	E2F3 TP53BP2	1.96e-04	8	93	2	15706352
Pubmed	EphA receptors direct the differentiation of mammalian neural precursor cells through a mitogen-activated protein kinase-dependent pathway.	MAP2K1 EPHA4	1.96e-04	8	93	2	15145949
Pubmed	Hetero-oligomer formation of mouse UDP-glucuronosyltransferase (UGT) 2b1 and 1a1 results in the gain of glucuronidation activity towards morphine, an activity which is absent in homo-oligomers of either UGT.	UGT2B15 UGT2B17	1.96e-04	8	93	2	32093886
Pubmed	Simultaneous evaluation of six human glucuronidation activities in liver microsomes using liquid chromatography-tandem mass spectrometry.	UGT2B15 UGT2B17	1.96e-04	8	93	2	22579593
Pubmed	A SUMOylation-dependent pathway mediates transrepression of inflammatory response genes by PPAR-gamma.	TBL1Y TBL1XR1	1.96e-04	8	93	2	16127449
Pubmed	The configuration of the 17-hydroxy group variably influences the glucuronidation of beta-estradiol and epiestradiol by human UDP-glucuronosyltransferases.	UGT2B15 UGT2B17	1.96e-04	8	93	2	18719240
Pubmed	Associations between polymorphisms in glucuronidation and sulfation enzymes and mammographic breast density in premenopausal women in the United States.	UGT2B15 UGT2B17	1.96e-04	8	93	2	20142249
Pubmed	Perinatal lethality of microtubule-associated protein 1B-deficient mice expressing alternative isoforms of the protein at low levels.	MAP4 MAPT	1.96e-04	8	93	2	11085878
Pubmed	Rett syndrome mutations abolish the interaction of MeCP2 with the NCoR/SMRT co-repressor.	TBL1Y TBL1XR1	1.96e-04	8	93	2	23770565
Pubmed	N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.	PCNP FLNA DST DSC1 MAP4 AHNAK RPRD2 RPS23 PRPF8 TP53BP2	2.01e-04	934	93	10	33916271
Pubmed	FBW7 suppresses ovarian cancer development by targeting the N6-methyladenosine binding protein YTHDF2.	FLNA GOPC AHNAK SBF2 MECOM RPS23 SUCLG1 PRPF8	2.13e-04	601	93	8	33658012
Pubmed	LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy.	FLNA MAP4 AHNAK BMS1 PRPF8	2.16e-04	202	93	5	33005030
Pubmed	The interactome of CLUH reveals its association to SPAG5 and its co-translational proximity to mitochondrial proteins.	FLNA ZNF106 MAP4 SUCLG2 SUCLG1	2.21e-04	203	93	5	35012549
Pubmed	JSAP1, a novel jun N-terminal protein kinase (JNK)-binding protein that functions as a Scaffold factor in the JNK signaling pathway.	MAP2K1 EPHA4	2.52e-04	9	93	2	10523642
Pubmed	Calsarcins, a novel family of sarcomeric calcineurin-binding proteins.	FLNA MYOZ1	2.52e-04	9	93	2	11114196
Pubmed	Variable impact of chronic stress on spatial learning and memory in BXD mice.	DSC1 PLCB1	2.52e-04	9	93	2	26079812
Pubmed	Establishment of tendon-derived cell lines exhibiting pluripotent mesenchymal stem cell-like property.	COMP EPHA4	2.52e-04	9	93	2	12837285
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	TLK2 DLGAP1 CTTNBP2 DST TBL1Y PLCB1 TBL1XR1 TP53BP2 EPHA4 SYNGAP1	2.56e-04	963	93	10	28671696
GeneFamily	UDP glucuronosyltransferases	UGT2A2 UGT2B15 UGT2B17	1.45e-04	32	58	3	363
GeneFamily	Zinc fingers C2H2-type\|ZF class homeoboxes and pseudogenes	SP1 ZNF106 TSHZ3 ZNF776 ZFP90 ZNF827 ZNF451 MECOM ZNF626	4.35e-04	718	58	9	28
Coexpression	LAKE_ADULT_KIDNEY_C14_DISTAL_CONVOLUTED_TUBULE	MAN1A1 DST SBF2 MECOM PARD3B PLPPR1 ABCA10	9.53e-06	208	93	7	M39233
Coexpression	LAKE_ADULT_KIDNEY_C2_PODOCYTES	CTTNBP2 DST TBC1D1 AHNAK SBF2 PARD3B MAML3	1.08e-05	212	93	7	M39221
Coexpression	LINDGREN_BLADDER_CANCER_CLUSTER_3_DN	LGMN DST ZNF827 AHNAK BMS1 MECOM RPS23	1.63e-05	226	93	7	M11238
Coexpression	VANLOO_SP3_TARGETS_DN	HIPK3 LGMN PDK1 UGT2B15 UGT2B17	3.36e-05	103	93	5	MM919
Coexpression	JAEGER_METASTASIS_DN	CDS1 CRYBG2 FAT2 DST CWH43 DSC1 AHNAK	3.99e-05	260	93	7	M10702
Coexpression	LAKE_ADULT_KIDNEY_C26_MESANGIAL_CELLS	DST TBC1D1 AHNAK SBF2 PCDH9 MAML3	4.08e-05	177	93	6	M39245
Coexpression	LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP	CDS1 DST ANGPT1 AHNAK MECOM PLS3	4.92e-05	183	93	6	M12621
Coexpression	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_UP	DST ANGPT1 MECOM HERC6 PCDH9 RAB27B	4.92e-05	183	93	6	M6670
Coexpression	BENPORATH_SUZ12_TARGETS	CWH43 COMP MAPT TBC1D1 PLCB1 MECOM RIPK4 VSX1 ARHGAP20 PLPPR1 PLS3 SIX2 EPHA4	7.31e-05	1035	93	13	M9898
Coexpression	GSE32986_GMCSF_AND_CURDLAN_LOWDOSE_VS_GMCSF_AND_CURDLAN_HIGHDOSE_STIM_DC_DN	ANO4 TSHZ3 DST NBEAL2 SLC4A10 MAML3	7.82e-05	199	93	6	M8622
Coexpression	GSE13306_RA_VS_UNTREATED_MEM_CD4_TCELL_DN	MAP4 CIART PDK1 AHNAK SBF2 RIPK4	8.04e-05	200	93	6	M3237
CoexpressionAtlas	DevelopingKidney_e15.5_Pelvic Mesenchyme_emap-8241_k-means-cluster#2_top-relative-expression-ranked_1000	ANO4 TSHZ3 ANGPT1 AHNAK PLCB1 CYP7B1 ARHGAP20 PCDH9	4.62e-05	305	90	8	gudmap_developingKidney_e15.5_Pelvic Mesenchyme_1000_k2
CoexpressionAtlas	DevelopingKidney_e15.5_Medullary collecting duct_emap-28063_k-means-cluster#1_top-relative-expression-ranked_1000	CDS1 SLC2A8 PDK1 TBC1D1 NBEAL2 RAB27B FAM110B	4.84e-05	225	90	7	gudmap_developingKidney_e15.5_Medullary collecting duct_1000_k1
CoexpressionAtlas	DevelopingLowerUrinaryTract_P2_bladder urothelium (LCM)_emap-30380_k-means-cluster#3_top-relative-expression-ranked_1000	ZNF106 CRYBG2 FAT2 DST NBEAL2 AHNAK RAB27B	5.88e-05	232	90	7	gudmap_developingLowerUrinaryTract_P2_bladder urothelium (LCM)_1000_k3
CoexpressionAtlas	DevelopingLowerUrinaryTract_P1_bladder_J_emap-30374_k-means-cluster#5_top-relative-expression-ranked_1000	ZNF106 CRYBG2 DST AHNAK RIPK4 RAB27B	6.37e-05	161	90	6	gudmap_developingLowerUrinaryTract_P1_bladder_J_1000_k5
CoexpressionAtlas	DevelopingLowerUrinaryTract_P2_bladder urothelium (LCM)_emap-30380_k-means-cluster#2_top-relative-expression-ranked_500	CRYBG2 DST NBEAL2 AHNAK RAB27B	8.46e-05	105	90	5	gudmap_developingLowerUrinaryTract_P2_bladder urothelium (LCM)_500_k2
ToppCell	droplet-Liver-LIVER_HEP-30m\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MAP4 MAPT AHNAK AMOTL1 MECOM PARD3B EPHA4	1.03e-07	180	93	7	dd1b10c7f5a0fbc63163844ca1882884a24a84d3
ToppCell	droplet-Liver-LIVER_HEP\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MAP4 MAPT AHNAK AMOTL1 MECOM PARD3B EPHA4	1.03e-07	180	93	7	423454e3390080ae03bb3cbb267255ebfe4df080
ToppCell	Mesenchymal-matrix_fibroblast_1_cell\|World / Lineage, Cell type, age group and donor	DLGAP1 TSHZ3 CTTNBP2 DST ANGPT1 CYP7B1 ARHGAP20	1.66e-07	193	93	7	acad568621ed677031797b8c2e34dafea798d681
ToppCell	Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	DLGAP1 TSHZ3 CTTNBP2 DST ANGPT1 CYP7B1 ARHGAP20	1.72e-07	194	93	7	011e14d9ed1393275f892060e7708ffadcd0767f
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	CTTNBP2 DST ANGPT1 SBF2 ARHGAP20 TBL1XR1 RAB27B	1.91e-07	197	93	7	31a1852911bda38543916585fda34255fd62a134
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	CTTNBP2 DST ANGPT1 SBF2 PARD3B ARHGAP20 TBL1XR1	1.91e-07	197	93	7	0034bae02ee7fcfea520d453ca3c842ab6963b12
ToppCell	COVID-19-Heart-Fib_+_CM\|Heart / Disease (COVID-19 only), tissue and cell type	COMP MAPT VSX1 AGBL1 SIX2	2.65e-06	104	93	5	0b60a56a46f1fe3f8224ec6399d009a34a117a21
ToppCell	moderate-Epithelial-Ionocyte\|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	CTTNBP2 DST TBC1D1 SRARP PLPPR1 FAM110B	2.86e-06	189	93	6	6011b747e27d61d222380a7bffdd921a68e9b657
ToppCell	critical-Epithelial-Ionocyte\|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	CTTNBP2 DST MAPT SRARP PLPPR1 FAM110B	2.94e-06	190	93	6	05a2c3549b68f49081723bf35db14974274419d5
ToppCell	Control-Stromal-Myofibroblast\|Stromal / Disease state, Lineage and Cell class	FLNA DLGAP1 DST ANGPT1 CYP7B1 MAML3	3.22e-06	193	93	6	5896242f713ae5fd1a4ebb63827f15d7279dced2
ToppCell	PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	TSHZ3 DST SBF2 ARHGAP20 TBL1XR1 RAB27B	3.42e-06	195	93	6	0e55fa5b3cbeb7baee3d4ac272a3bf80381ec937
ToppCell	COVID-19-Fibroblasts-Alveolar_FB\|COVID-19 / group, cell type (main and fine annotations)	CTTNBP2 DST ANGPT1 CYP7B1 PARD3B ABCA10	3.42e-06	195	93	6	603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7
ToppCell	PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	CTTNBP2 DST ANGPT1 PARD3B ARHGAP20 TBL1XR1	3.63e-06	197	93	6	11a4c417f035e554431a8f03be13b5eefa3530c0
ToppCell	(00)_Basal\|World / shred by cell type and Timepoint	FAT2 DST AHNAK AMOTL1 RPS23	1.53e-05	149	93	5	49e39206f37cee124ca4763c79425b805e50624b
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	PLCB1 MECOM PLPPR1 PCDH9 EPHA4	2.16e-05	160	93	5	03b88dc7ad41c6ae443cab7e77ec666340bf432e
ToppCell	356C-Fibroblasts-Fibroblast-G-\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	DST ANGPT1 MAPT PCARE RIPK4	2.16e-05	160	93	5	0293b244c063a62819690bf22bbc2681f8d15252
ToppCell	356C-Fibroblasts-Fibroblast-G\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	DST ANGPT1 MAPT PCARE RIPK4	2.16e-05	160	93	5	3eaae86fa08f7651021316f8e5811bf48055591e
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c08-GZMK-FOS_h\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	CDS1 AHNAK AMOTL1 HERC6 EPHA4	2.16e-05	160	93	5	529034a1101d7772d82f86beb5c6fa9c9dd97067
ToppCell	severe_influenza-cDC\|severe_influenza / disease group, cell group and cell class (v2)	LGMN CDS1 CTTNBP2 AMOTL1 MECOM	2.22e-05	161	93	5	7716315b8bda904b346cea47edc2c0b507a345c2
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c09-GZMK-FOS_l\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	DLGAP1 CD4 GIMAP8 MAPT RAB27B	2.36e-05	163	93	5	e4077e587895c85bc806be05ff5d451088e39468
ToppCell	Children_(3_yrs)-Mesenchymal-vascular_smooth_muscle_cell-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	FLNA ANGPT1 MYOZ1 TBC1D1 PLCB1	2.50e-05	165	93	5	8a82e20c9b1156bb4bbc16f7785abb04458d671b
ToppCell	TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-5\|TCGA-Ovary / Sample_Type by Project: Shred V9	SP1 RPRD2 CPLANE1 MAML3 SYNGAP1	2.57e-05	166	93	5	32d2eaf8a5d03881bf74d680825af2d5110b082d
ToppCell	NS-critical-d_16-33-Epithelial-Ionocyte\|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	CTTNBP2 DST ANGPT1 SRARP FAM110B	2.73e-05	168	93	5	6a233045638cb83dab64789b996b7598c325001e
ToppCell	Transplant_Alveoli_and_parenchyma-Epithelial-Basal_1\|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X	USP49 TSHZ3 TBL1Y PARD3B RIPK4	2.88e-05	170	93	5	aabe993c9f337b1caaeb0e64626a3920579c41b7
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex-lymphatic_endothelial_cell_of_renal_cortex\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	MAN1A1 PDK1 TDRD10 CREG2 TCTN1	3.31e-05	175	93	5	9a96a946db731ba24c9be34bedebf1f4a1372b9e
ToppCell	390C-Lymphocytic-NK_cells-NK_cell_A2\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	ZNF106 CRYBG2 DST ZNF451 PCDH9	3.31e-05	175	93	5	334fad1a147de6c007cec5089c02c35cf3220f1b
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-lymphatic_endothelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	MAN1A1 PDK1 TDRD10 CREG2 TCTN1	3.31e-05	175	93	5	54c1f080195ad8392a095e83b56a4b54073d4c0d
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	MAN1A1 PDK1 TDRD10 CREG2 TCTN1	3.31e-05	175	93	5	2b51406a2c2daa13ab4ed283ede038cd11d9e641
ToppCell	390C-Lymphocytic-NK_cells-NK_cell_A2\|NK_cells / Donor, Lineage, Cell class and subclass (all cells)	ZNF106 CRYBG2 DST ZNF451 PCDH9	3.31e-05	175	93	5	da191dfb8a7f976a632a3a0b923942ab54f5c8c1
ToppCell	AT1-AT2_cells-IPF_04\|World / lung cells shred on cell class, cell subclass, sample id	DST UGT2B15 VWCE PLS3 RAB27B	3.40e-05	176	93	5	f86832cfeff5b3cfffe4455c1b96a1420d48ba1e
ToppCell	NS-moderate-d_07-13-Epithelial-Ionocyte\|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	CTTNBP2 DST TBC1D1 PLPPR1 FAM110B	3.50e-05	177	93	5	99500aed584f793aaf308f8afbf5d1c6a9b4ee55
ToppCell	NS-moderate-d_16-33-Epithelial-Ionocyte\|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	CTTNBP2 DST SRARP PLPPR1 FAM110B	3.79e-05	180	93	5	8af8b4af2dc72223ac71fc027e0d4280c5dd81f8
ToppCell	facs-Liver-Non-hepatocytes-3m-Lymphocytic-T_cell\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PACRGL CD4 ZNF827 E2F3 HERC3	3.79e-05	180	93	5	87347af8f28cf7c486c19f3f98c0afb022c323b5
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	DLGAP1 CTTNBP2 ANGPT1 CYP7B1 ABCA10	3.89e-05	181	93	5	9ede19228ba5c0668a9c06c915510b95585216ef
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	DST PLCB1 MECOM PCDH9 ABCA10	3.99e-05	182	93	5	a8cc56f32efe180e8fb5d69dbe606a794b3db700
ToppCell	NS-critical-d_07-13-Epithelial-Ionocyte\|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	CTTNBP2 DST SRARP PLPPR1 FAM110B	4.10e-05	183	93	5	ba43bca2b45be1008eebd3f033cecb061fb3a966
ToppCell	3'-Broncho-tracheal-Epithelial-Neuro-endocrine/ionocytic-ionocyte-Ionocyte-Ionocyte_L.0.7.0.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ANO4 CTTNBP2 TBC1D1 SRARP PLPPR1	4.21e-05	184	93	5	a60802e11dcc5f932811260b08a95a32f60f6b19
ToppCell	3'-Broncho-tracheal-Epithelial-Neuro-endocrine/ionocytic-ionocyte\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ANO4 CTTNBP2 TBC1D1 SRARP PLPPR1	4.21e-05	184	93	5	39c230d32e4259bc784e0edfd9e2884c96898564
ToppCell	3'-Broncho-tracheal-Epithelial-Neuro-endocrine/ionocytic-ionocyte-Ionocyte\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ANO4 CTTNBP2 TBC1D1 SRARP PLPPR1	4.21e-05	184	93	5	2a2fb691cc9414ef5b06c26239d2da03d6d7e5c2
ToppCell	TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-4\|TCGA-Pancreas / Sample_Type by Project: Shred V9	HIPK3 ZNF106 ANGPT1 CYP7B1 PCDH9	4.21e-05	184	93	5	67164bb6bcae7322cb89b585c7aa10bce35b0ecd
ToppCell	critical-Epithelial-Ionocyte\|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	CTTNBP2 DST SRARP PLPPR1 FAM110B	4.21e-05	184	93	5	58d36577eff814d46d72f031f3533d71549e3d6e
ToppCell	CV-Moderate-4\|CV / Virus stimulation, Condition and Cluster	CIART PDK1 VWCE MAP2K1 PLS3	4.21e-05	184	93	5	90f5b447064743246b09a6c47bf561efafa15e1f
ToppCell	PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro2_(5)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	ANO4 DLGAP1 DST ANGPT1 MECOM	4.32e-05	185	93	5	9f19f04fc4d97dfc2dd78cde77b515f1cb5d51ec
ToppCell	CV-Moderate-4\|Moderate / Virus stimulation, Condition and Cluster	CIART PDK1 VWCE MAP2K1 PLS3	4.32e-05	185	93	5	4a3ce0c603c2ffe11f0f00775b6af4f6d9a6070a
ToppCell	Severe-CD8+_T\|Severe / Disease group and Cell class	AHNAK PLCB1 RAB27B EPHA4	4.34e-05	93	93	4	433d23253b2102cf65df338a488554e5ab409d7e
ToppCell	PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	ANO4 TSHZ3 SBF2 ARHGAP20 PLS3	4.54e-05	187	93	5	a9316e2818217ec5feae9cf8816f7249803caee6
ToppCell	droplet-Bladder-BLADDER-1m-Epithelial-bladder_urothelial_cell\|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CDS1 FAT2 NBEAL2 MECOM RAB27B	4.54e-05	187	93	5	aa336fb568a24e12c0454265ddd71ed10a6614cf
ToppCell	moderate-Epithelial-Ionocyte\|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	CTTNBP2 DST SRARP PLPPR1 FAM110B	4.54e-05	187	93	5	3e3fe2d5712a0ac477cddefe56705d4b8d8f7eac
ToppCell	Control-Epithelial-ATI\|Epithelial / Disease state, Lineage and Cell class	FLNA DST NBEAL2 AHNAK PLS3	4.54e-05	187	93	5	3a032432f780525f4f4c2a358897d9989b1ecae7
ToppCell	CD8+_Memory_T_cell-CV-4\|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster	CIART PDK1 VWCE MAP2K1 PLS3	4.54e-05	187	93	5	9c2fc2f259fa7d3a65fb99c295ac378e03d9aa6c
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ANGPT1 CWH43 MECOM PCDH9 FAM110B	4.66e-05	188	93	5	4154f4787483c7e076e87a187733a9f666742c3d
ToppCell	COVID_vent-Myeloid-Monocytic-SC_&_Eosinophil\|COVID_vent / Disease condition, Lineage, Cell class and subclass	DST ANGPT1 MECOM PCDH9 PLS3	4.78e-05	189	93	5	2157a2d40613f7d5ce2e7dbd266df441e449cdaf
ToppCell	5'-Adult-Appendix-Mesenchymal-Pericytes\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	FLNA ANGPT1 MYOZ1 TBC1D1 PLS3	4.78e-05	189	93	5	0daa8efac08dca9525d2b8d421952068cab4eb50
ToppCell	Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	DLGAP1 CTTNBP2 DST ANGPT1 ARHGAP20	4.78e-05	189	93	5	203c80030df08ae112f9ae4043709f455d87ce89
ToppCell	5'-Adult-Appendix-Mesenchymal-Pericytes-Contractile_pericyte_(PLN+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	FLNA ANGPT1 MYOZ1 TBC1D1 PLS3	4.78e-05	189	93	5	b6bb4327b4560d07d2b728abcc5f144f428948a5
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_myocytic-mes_immature_ASM2_(12)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	ANO4 FLNA DLGAP1 PLCB1 PLS3	4.78e-05	189	93	5	0abc7a4900cc9033bc1be69b770ccc54a6bf41b4
ToppCell	IPF-Epithelial-Basal\|Epithelial / Disease state, Lineage and Cell class	TSHZ3 FAT2 DST AMOTL1 PLS3	4.90e-05	190	93	5	4f15842b424eefadbfe451875e517cf70e29607f
ToppCell	PND10\|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	FLNA DST MAP4 AHNAK AMOTL1	4.90e-05	190	93	5	d67e2814047c8df2ae4b7bc8be9539f5df6ecef2
ToppCell	(5)_Fibroblasts-(5)_Fibroblast-C_(Myofibroblast)\|(5)_Fibroblasts / Lung cell shreds - cell class (v4) and cell subclass (v4)	ZNF106 CD4 DST ANGPT1 CYP7B1	4.90e-05	190	93	5	71e112dfb8c3190fe0286b45a046ea789eb6a8db
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	DLGAP1 TSHZ3 DST ANGPT1 PLCB1	5.02e-05	191	93	5	c54c420a94dc749ebc67fc64c5614663f4b9798d
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Mesenchymal\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	DLGAP1 TSHZ3 DST ANGPT1 PLCB1	5.02e-05	191	93	5	806b94f567ea09a9f443cd4091e70cdb1253ac08
ToppCell	PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	CTTNBP2 ANGPT1 AHNAK PCDH9 FAM110B	5.02e-05	191	93	5	fa380a8752de158974b2ae5e741573439719cc0d
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	DLGAP1 TSHZ3 DST ANGPT1 PLCB1	5.02e-05	191	93	5	cb0aee740b08f7d5fdd2717ecf7429043b277ae7
ToppCell	3'-Broncho-tracheal-Endothelial-Blood_vessel_EC-pulmonary_artery_endothelial_cell-EC_arterial\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	GIMAP8 PLCB1 MECOM PLS3 EPHA4	5.02e-05	191	93	5	04c7aa2e39fdd08ca24c10d43b29a5e41a73b9e0
ToppCell	3'-Broncho-tracheal-Endothelial-Blood_vessel_EC-pulmonary_artery_endothelial_cell\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	GIMAP8 PLCB1 MECOM PLS3 EPHA4	5.02e-05	191	93	5	db8dd6bbba803585bdd6a55d5c403d383f2e9acf
ToppCell	LPS-antiTNF-Endothelial-Endothelial-Artery\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CTTNBP2 PLCB1 MECOM TDRD10 EPHA4	5.02e-05	191	93	5	4b3d5157344dbfbf4fab518611cd9fa37fac7bd9
ToppCell	nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	DST ANGPT1 CYP7B1 PARD3B ABCA10	5.02e-05	191	93	5	6688cee34beee4f151ac17fccbc9c26a9aad72e1
ToppCell	nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	DST ANGPT1 CYP7B1 PARD3B ABCA10	5.15e-05	192	93	5	99ce9e3c4c50cf64ebb62145f2b5420efa0db309
ToppCell	COPD-Stromal-Myofibroblast\|Stromal / Disease state, Lineage and Cell class	ZNF106 DST ANGPT1 CYP7B1 MAML3	5.15e-05	192	93	5	62904f94dfce430456f05066522cbf9bd29f4d7e
ToppCell	3'-Broncho-tracheal-Endothelial-Blood_vessel_EC-pulmonary_artery_endothelial_cell-EC_arterial-EC_arterial_L.2.4.1.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	GIMAP8 PLCB1 MECOM PLS3 EPHA4	5.28e-05	193	93	5	3a9fe4e709c09ec787c71bdd6b58a71c419896de
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	DLGAP1 DST ANGPT1 CYP7B1 PARD3B	5.28e-05	193	93	5	b3ad5ff480d99217f36cc7471e5a96a519ddb409
ToppCell	human_hepatoblastoma\|World / Sample and Cell Type and Tumor Cluster (all cells)	DLGAP1 PLCB1 PARD3B RPS23 PLPPR1	5.28e-05	193	93	5	e6a688bc834f845ff64dae1be64f073eec5091a1
ToppCell	facs-Bladder-nan-3m-Epithelial-bladder_urothelial_cell\|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CDS1 MECOM RPS23 RIPK4 RAB27B	5.41e-05	194	93	5	1531dcace28a14bd700e909a027426a8cee20337
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	TSHZ3 DST SBF2 ARHGAP20 RAB27B	5.41e-05	194	93	5	b1bb0f846d2865efdd9bc8842b16b9d069785882
ToppCell	Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	DLGAP1 DST ANGPT1 CYP7B1 ARHGAP20	5.41e-05	194	93	5	35f132cc38ac133be01834ed0946188aa0757eb4
ToppCell	10x5'-GI_small-bowel-Lymphocytic_T_CD4\|GI_small-bowel / Manually curated celltypes from each tissue	DLGAP1 CD4 AHNAK SLC4A10 PLCB1	5.41e-05	194	93	5	4547b57669be5d4f0de55175802ee04372288a6a
ToppCell	PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	ANO4 DLGAP1 TSHZ3 ARHGAP20 PLS3	5.54e-05	195	93	5	c5d2d9f12fd893331c9de261af30607d845d4f6a
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_adventitial_fibro_(9)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	TSHZ3 SBF2 PARD3B ARHGAP20 ABCA10	5.54e-05	195	93	5	70387a62f121f8c374dba1aca9ab65cfed6a0b10
ToppCell	Children_(3_yrs)-Immune-monocyte-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	TBC1D1 PLCB1 E2F3 MAP2K1 MAML3	5.54e-05	195	93	5	81a28289eda1a8a1a31b7357106f64ac5000e172
ToppCell	Brain_organoid-organoid_Velasco_nature-3_mon-Neuronal-CFuPNs\|3_mon / Sample Type, Dataset, Time_group, and Cell type.	TSHZ3 CTTNBP2 MAPT ARHGAP20 PCDH9	5.54e-05	195	93	5	574354ef4bcefeb9856b65d19bb92e2cffe5dc7a
ToppCell	Children_(3_yrs)-Immune-monocyte\|Children_(3_yrs) / Lineage, Cell type, age group and donor	SBF2 PLCB1 E2F3 MAP2K1 MAML3	5.68e-05	196	93	5	cacd69be72e6167814f7adea7c5fa114f3103bbb
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	DST ANGPT1 SBF2 PARD3B ARHGAP20	5.68e-05	196	93	5	1450cb69c5bf469e97c03bf1890f6f7c54165b8a
ToppCell	Children_(3_yrs)-Mesenchymal\|Children_(3_yrs) / Lineage, Cell type, age group and donor	DLGAP1 DST ANGPT1 CYP7B1 ABCA10	5.68e-05	196	93	5	bc94909f9b2dc08a59eef1914148b69720569c8f
ToppCell	nucseq-Mesenchymal-Fibroblastic\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	DST ANGPT1 CYP7B1 PARD3B ABCA10	5.68e-05	196	93	5	7d8505dac15fa59935ccf592afc54b04c4c6554f
ToppCell	AT2_cells-IPF_04\|World / lung cells shred on cell class, cell subclass, sample id	DLGAP1 UGT2B15 MECOM AGBL1 PCDH9	5.82e-05	197	93	5	fd7bdfa6bf5966ebc11fdd13915769429540ddbf
ToppCell	5'-Adult-LargeIntestine-Mesenchymal-Pericytes-Contractile_pericyte_(PLN+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	FLNA ANGPT1 MYOZ1 TBC1D1 PLS3	5.82e-05	197	93	5	d16bb765afdc02406ffd7ce6a75bae72b66db66c
ToppCell	COVID-19-Fibroblasts\|COVID-19 / group, cell type (main and fine annotations)	DST ANGPT1 CYP7B1 PARD3B ABCA10	5.82e-05	197	93	5	fb847f2277609c31fffcdf49517243ce0684facf
ToppCell	Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_myofibroblast\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ANO4 DST ANGPT1 COMP PLCB1	5.82e-05	197	93	5	6d0d68d460243a0259ada93ebda40fa7b3088eeb
ToppCell	10x5'-GI_small-bowel-Lymphocytic_T_CD4-Trm_Th1/Th17\|GI_small-bowel / Manually curated celltypes from each tissue	DLGAP1 CD4 AHNAK SLC4A10 RPS23	5.96e-05	198	93	5	f4fc0cac858fc6dcd779d7959ccec51f78ea8cc2
ToppCell	facs-Tongue-nan-3m-Epithelial\|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DST AHNAK RPS23 RIPK4 PLS3	5.96e-05	198	93	5	2f03f8897dd7cce6d8296638e14e11ec16bcf624
ToppCell	5'-Adult-LargeIntestine-Epithelial-epithelial_progenitor_cell\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CWH43 UGT2B17 MECOM SUCLG2 SUCLG1	5.96e-05	198	93	5	08982f9e37591261975ddff9b9a6a59ba836fc0f
ToppCell	nucseq-Mesenchymal\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	DST ANGPT1 CYP7B1 PARD3B ABCA10	5.96e-05	198	93	5	8f52243ca8b9ba68a75ae411506a3a6de258eb97
ToppCell	facs-Tongue-nan-3m\|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DST AHNAK RPS23 RIPK4 PLS3	5.96e-05	198	93	5	f2a4057f038ef7225a5b98a7ab068c30dff4eadd
ToppCell	Brain_organoid-organoid_Paulsen_bioRxiv-1_mon-Neuronal\|1_mon / Sample Type, Dataset, Time_group, and Cell type.	MAP4 MAPT CREG2 PLPPR1 PCDH9	6.10e-05	199	93	5	f94307958cead25d38103fcbb35fa45011de1687
ToppCell	ILEUM-non-inflamed-(6)_ILC-(6)_ILC3\|(6)_ILC / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	MAN1A1 DST SLC4A10 RPS23 PCDH9	6.10e-05	199	93	5	ba144739f65560207303c0143e8de1e86922bebb
ToppCell	wk_20-22-Mesenchymal-Myofibro_&_SMC\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	ANO4 FLNA MAPT PLCB1 PLS3	6.10e-05	199	93	5	aacd3ffa40a6e6f435aa9be5b959d88812eb69d4
ToppCell	PCW_10-12-Mesenchymal\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	TSHZ3 DST ANGPT1 ARHGAP20 FAM110B	6.10e-05	199	93	5	a09292de4c4447b8eee55d401808e43b817321cc
ToppCell	Tracheal-NucSeq\|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations	SBF2 MECOM PARD3B TBL1XR1 MAML3	6.10e-05	199	93	5	94b94b17ca18b8dc27b91da1f2ccf89e03cc7035
ToppCell	Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-PAX6\|Neuronal / cells hierarchy compared to all cells using T-Statistic	ANGPT1 PLPPR1 MAML3 PLS3 FAM110B	6.25e-05	200	93	5	8a8f9d9e5ffab3f736c4bd0a5bb616d442d137d1
ToppCell	LPS_IL1RA-Endothelial-Endothelial-Artery\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	CTTNBP2 DST SRARP PLCB1 MECOM	6.25e-05	200	93	5	ac9ead34afa14067171833f5c277eaf06db7b02e
Disease	cholic acid glucuronide measurement	UGT2B15 UGT2B17	2.75e-05	3	90	2	EFO_0800574
Disease	sensory system disease (implicated_via_orthology)	TBL1Y TBL1XR1	2.75e-05	3	90	2	DOID:0050155 (implicated_via_orthology)
Disease	X-25937 measurement	UGT2B15 UGT2B17	5.50e-05	4	90	2	EFO_0800937
Disease	progressive supranuclear palsy	SP1 MAPT BMS1	1.16e-04	31	90	3	MONDO_0019037
Disease	response to selective serotonin reuptake inhibitor	TSHZ3 TBC1D1 MAP2K1 AGBL1	1.18e-04	82	90	4	EFO_0005658
Disease	hypertrophic cardiomyopathy	AHNAK SRARP PARD3B PLPPR1	1.84e-04	92	90	4	EFO_0000538
Disease	X-24574 measurement	UGT2B15 UGT2B17	1.91e-04	7	90	2	EFO_0800897
Disease	Neurodevelopmental Disorders	DLGAP1 PARD3B TBL1XR1 SYNGAP1	1.92e-04	93	90	4	C1535926
Disease	cortical surface area measurement	ANO4 SP1 ZNF106 CTTNBP2 ANGPT1 MAPT AMZ1 SLC4A10 MECOM PARD3B SLC25A26 AGBL1 EPHA4	2.17e-04	1345	90	13	EFO_0010736
Disease	deoxycholic acid glucuronide measurement	UGT2B15 UGT2B17	2.55e-04	8	90	2	EFO_0800575
Disease	memory performance	ANO4 ANGPT1 MECOM PRPF8 ARMC2 AGBL1 EPHA4	2.60e-04	409	90	7	EFO_0004874
Disease	open-angle glaucoma	CTTNBP2 DST ANGPT1 MAPT MECOM	3.04e-04	191	90	5	EFO_0004190
Disease	red blood cell density measurement	USP49 SP1 ZNF106 DST ANGPT1 GIMAP8 ZNF827 MAPT SBF2 MECOM	3.51e-04	880	90	10	EFO_0007978
Disease	tauopathy (implicated_via_orthology)	MAP4 MAPT	4.07e-04	10	90	2	DOID:680 (implicated_via_orthology)
Disease	4-androsten-3alpha,17alpha-diol monosulfate (3) measurement	UGT2B15 UGT2B17	4.07e-04	10	90	2	EFO_0022090
Disease	neuroticism measurement	CTTNBP2 MAN1A1 MAPT SBF2 SLC4A10 CYP7B1 AGBL1 PCDH9 RAB27B EPHA4	4.53e-04	909	90	10	EFO_0007660
Disease	DNA repair protein RAD51 homolog 4 measurement	UGT2B15 UGT2B17	4.97e-04	11	90	2	EFO_0801531
Disease	Calcium channel blocker use measurement	MAP4 SBF2 SLC4A10 PLCB1 MECOM	5.00e-04	213	90	5	EFO_0009930
Disease	cardiac troponin T measurement	TLK2 DLGAP1 MAPT TBC1D1 MECOM	5.67e-04	219	90	5	EFO_0005043
Disease	pulmonary function measurement, forced expiratory volume, smoking behaviour measurement	MECOM ARMC2	5.95e-04	12	90	2	EFO_0003892, EFO_0004314, EFO_0005671
Disease	5alpha-androstan-3beta,17beta-diol monosulfate (2) measurement	UGT2B15 UGT2B17	5.95e-04	12	90	2	EFO_0800291
Disease	Cakut	TBC1D1 SIX2	7.02e-04	13	90	2	C1968949
Disease	androstenediol (3alpha, 17alpha) monosulfate (3) measurement	UGT2B15 UGT2B17	7.02e-04	13	90	2	EFO_0800293
Disease	X-19141 measurement	UGT2B15 UGT2B17	7.02e-04	13	90	2	EFO_0800799
Disease	5alpha-androstan-3alpha,17alpha-diol monosulfate measurement	UGT2B15 UGT2B17	8.17e-04	14	90	2	EFO_0800283
Disease	response to opioid	DLGAP1 ANGPT1 PCDH9	8.69e-04	61	90	3	EFO_0008541
Disease	interstitial lung disease	CWH43 MAPT PLPPR1	1.14e-03	67	90	3	EFO_0004244
Disease	oral motor function measurement	LGMN DLGAP1	1.21e-03	17	90	2	EFO_0021793
Disease	white matter microstructure measurement	CTTNBP2 MAN1A1 MAPT AMZ1 MECOM AGBL1	1.26e-03	390	90	6	EFO_0005674
Disease	Carcinoma of bladder	TBL1XR1 EPHA4	1.36e-03	18	90	2	C0699885
Disease	5alpha-androstan-3alpha,17beta-diol monosulfate (1) measurement	UGT2B15 UGT2B17	1.36e-03	18	90	2	EFO_0800288
Disease	brain measurement, neuroimaging measurement	CTTNBP2 ANGPT1 AMZ1 SLC4A10 SLC25A26 AGBL1 EPHA4	1.48e-03	550	90	7	EFO_0004346, EFO_0004464
Disease	response to methotrexate, juvenile idiopathic arthritis	ANO4 CTTNBP2	1.52e-03	19	90	2	EFO_0002609, GO_0031427
Disease	osteochondrodysplasia (is_implicated_in)	FLNA COMP	1.52e-03	19	90	2	DOID:2256 (is_implicated_in)
Disease	neuroticism measurement, wellbeing measurement, depressive symptom measurement	MAN1A1 MAML3	1.52e-03	19	90	2	EFO_0007006, EFO_0007660, EFO_0007869
Disease	etiocholanolone glucuronide measurement	UGT2B15 UGT2B17	1.52e-03	19	90	2	EFO_0800362
Disease	neuroimaging measurement	SP1 ZNF106 CTTNBP2 ANGPT1 MAPT AMZ1 SLC4A10 SLC25A26 AGBL1 EPHA4	1.55e-03	1069	90	10	EFO_0004346
Disease	stem Cell Growth Factor beta measurement	MAN1A1 MAP4 PCDH9	1.58e-03	75	90	3	EFO_0008292
Disease	Osteoarthritis of hip	COMP MAPT	1.69e-03	20	90	2	C0029410
Disease	Familial aplasia of the vermis	CPLANE1 TCTN1	1.69e-03	20	90	2	cv:C0431399
Disease	androsterone glucuronide measurement	UGT2B15 UGT2B17	1.69e-03	20	90	2	EFO_0800317
Disease	Joubert syndrome 1	CPLANE1 TCTN1	1.86e-03	21	90	2	C4551568
Disease	Epilepsy, Cryptogenic	FLNA SLC4A10 SYNGAP1	2.04e-03	82	90	3	C0086237
Disease	Awakening Epilepsy	FLNA SLC4A10 SYNGAP1	2.04e-03	82	90	3	C0751111
Disease	Aura	FLNA SLC4A10 SYNGAP1	2.04e-03	82	90	3	C0236018
Disease	Splenomegaly	MAPT MECOM	2.04e-03	22	90	2	C0038002
Disease	X-24947 measurement	UGT2B15 UGT2B17	2.04e-03	22	90	2	EFO_0800910
Disease	Autism Spectrum Disorders	TSHZ3 CTTNBP2 PCDH9	2.26e-03	85	90	3	C1510586
Disease	smoking status measurement, chronic obstructive pulmonary disease	AMZ1 MECOM ARMC2	2.50e-03	88	90	3	EFO_0000341, EFO_0006527
Disease	epiandrosterone sulfate measurement	UGT2B15 UGT2B17	2.64e-03	25	90	2	EFO_0021120
Disease	forced expiratory volume	TSHZ3 DST AHNAK MECOM PARD3B RPRD2 SUCLG2 ARMC2	2.84e-03	789	90	8	EFO_0004314
Disease	Antiglaucoma preparations and miotics use measurement	ANGPT1 MECOM	2.85e-03	26	90	2	EFO_0009944
Disease	unipolar depression, depressive symptom measurement	CTTNBP2 MAML3	2.85e-03	26	90	2	EFO_0003761, EFO_0007006

Protein segments in the cluster

Peptide	Gene	Start	Entry
QTTLLGTTHKNPKAG	C2orf16	1961	Q68DN1
TFQAGPHAVKKLSSG	CCL25	106	O15444
FKIKDFANTIPGHGG	CDS1	381	Q92903
HTDGILSFLKNNKPG	AMZ1	156	Q400G9
GLLGHNGAGKSTSIK	ABCA10	1236	Q8WWZ4
KGTTSLPSHLKNGGD	ARMC2	211	Q8NEN0
PTHQGVGLAFAKANK	COMP	161	P49747
VSVGHKGGKPGLTIQ	AHNAK	336	Q09666
QGHLESGSGKVTFPK	AHNAK	5646	Q09666
KQHLPGSGNGKGFKV	AMOTL1	276	Q8IY63
KSHSLEGPSKGSVNG	DLGAP1	151	O14490
KGHTGTAGKQSSLIL	ANGPT1	406	Q15389
SGITNGKTKVFHPEG	ANO4	6	Q32M45
LETGDVHKGKSGPNT	BMS1	786	Q14692
TVSTHKKIQGLPFGN	CREG2	141	Q8IUH2
GAASQTKGSKIHPVG	TP53BP2	396	Q13625
TGRSTVHLGSKKNPG	AGBL1	421	Q96MI9
AGNGGVVFKVSHKPS	MAP2K1	76	Q02750
QGPNGSSGKAFKVHL	RAB27B	56	O00194
GHDQDSLKKSQGVGP	GOPC	271	Q9HD26
NQHSLLFGGKGKGSP	PDK1	196	Q15118
PRKNHVFGGKKGSNV	MECOM	791	Q03112
PVHGKSGLKTANLTG	PARD3B	321	Q8TEW8
STENIKHQPGGGRAK	MAP4	941	P27816
RAKKSGAGTGKQQHP	MAML3	121	Q96JK9
HGKGVVGLFKSQNSP	SBF2	1201	Q86WG5
QGAPVGSLSVKNKAH	DST	2461	Q03001
HGQLGLGKEFPSQAS	HERC3	166	Q15034
GKNLKLTLGHTTGSG	KIAA2026	1366	Q5HYC2
GSGVHYTPQQNGLKT	EPHA4	381	P54764
TSAGPNSFNKGKHGF	PCNP	141	Q8WW12
KHPAKFSLVGIGGQD	PLS3	471	P13797
IGGNQLGHFTIHPKK	FAT2	3361	Q9NYQ8
CSSQGGFKTKGPLHT	PCDH9	996	Q9HC56
SHGQLGLGKEFPSQA	HERC6	156	Q8IVU3
GNSHPPTKGSAFQTK	HIPK3	51	Q9H422
PLNIKTGKSGIGHEA	GPATCH11	126	Q8N954
SGHQYLSDGLKTPKG	E2F3	141	O00716
TKKHGSAGLAPQTKQ	CPLANE1	3091	Q9H799
GFGQTTAKRHPSQGQ	CTTNBP2	1381	Q8WZ74
HGPGIQSGTTNKPNK	FLNA	1361	P21333
GSKNFQSHGPIFSKK	CRYBG2	86	Q8N1P7
SGKSATGNAILGKHV	GIMAP8	21	Q8ND71
ILGNQGSFLTKGPSK	CD4	61	P01730
GLNELKPISKGGHSS	MAN1A1	216	P33908
KPISKGGHSSSLFGN	MAN1A1	221	P33908
SNKGGGHQTLESVKG	DSC1	791	Q08554
PTLKVFGNHAKTESG	FAM110B	96	Q8TC76
LQSTGQKKGSGFPIH	CYP7B1	326	O75881
KTRLQSPQGFSKAGG	SLC25A26	31	Q70HW3
KIHNFLKGNPGFSGL	RPRD2	671	Q5VT52
KIVSGKYHPGQSQGS	KRBA2	346	Q6ZNG9
AKDIPFKTQGSHGSQ	PCARE	111	A6NGG8
QHGGSGSLSIIKSKI	PACRGL	226	Q8N7B6
TLGHLINSGTNPGKT	CWH43	301	Q9H720
SLSGSEGNHVKLFPK	ARHGAP20	781	Q9P2F6
SSGGKLAGHQKTVPT	SRARP	26	Q8NEQ6
SHPQLSDKLFGKNGV	TDRD10	6	Q5VZ19
KLTQGGPGNSSHVAI	SLC2A8	341	Q9NY64
SGHNTQGLVLPLGKS	NBEAL2	926	Q6ZNJ1
KTHQNKKGGPGVALS	SP1	706	P08047
VHNFKGTQGSPSKPK	PLPPR1	276	Q8TBJ4
LQSLKFQGGHGPAAT	RIPK4	811	P57078
GNLASTLGQHKGPIF	TBL1XR1	256	Q9BZK7
GGQTHLGLPVFNTVK	SUCLG1	91	P53597
ETSQGKGTPRGHKIS	TLK2	71	Q86UE8
AAQKSSLGGGKHQLT	CIART	196	Q8N365
SLGGGKHQLTKHFPS	CIART	201	Q8N365
HKTFEGNLTTKPING	PRPF8	1791	Q6P2Q9
TKKVHPGAGAQGGSN	VSX1	336	Q9NZR4
LKANPFGGASHAKGI	RPS23	36	P62266
FNSGLKGGVHLTKDP	SUCLG2	96	Q96I99
SFKLGDNKGIAHPIS	ZNF451	281	Q9Y4E5
KGHGPGGQATNKTSN	MTRFR	66	Q9H3J6
GGGLKPSITKQHSQT	SYNGAP1	1126	Q96PV0
IQEKTGSKPRSGGNH	SMIM9	36	A6NGZ8
PLGTKAGDGQTPQKH	SLC5A10	556	A0PJK1
TVDFSKGLGGQQKGH	SLC4A10	281	Q6U841
SKANHLGDSGGTPVK	TBC1D1	641	Q86TI0
GFQPHKGSGIIQTTN	TCTN1	391	Q2MV58
HLFPKATNGKTQLSG	USP49	291	Q70CQ1
EKQGLSPHGNVAFSK	VWCE	751	Q96DN2
KIGSTENLKHQPGGG	MAPT	576	P10636
SHSFQGPNLVTGKGL	RPAP1	201	Q9BWH6
GNLASTLGQHKGPIF	TBL1Y	266	Q9BQ87
GKVNHKTPSSEELGG	PLCB1	1191	Q9NQ66
GGTKFLKNLDTGHPV	TSHZ3	961	Q63HK5
NSHNPLNGSGKSVLG	SIX2	196	Q9NPC8
QFPNSNGQKRGHTGK	ZNF626	156	Q68DY1
KKCHTVPTGGLNSGQ	ZNF827	1066	Q17R98
HPKTKAFITHGGTNG	UGT2B15	366	P54855
PHVLKGNKSTFGSQK	ZNF106	511	Q9H2Y7
HPKTKAFITHGGTNG	UGT2B17	366	O75795
GHPKTKAFITHGGTN	UGT2A2	371	P0DTE5
KTHKGEGAFPNGTDQ	ZFP90	231	Q8TF47
SNFETKHGIPLQGGK	ZNF776	191	Q68DI1
GIGSGKVLKSGPQDH	LGMN	126	Q99538
HFQKFLPTVGGQLGT	MYOZ1	86	Q9NP98